Agreement and Diagnostic Performance of Urinary HPV Testing Versus Clinician-Collected Cervico-Vaginal Sampling: A Prospective Cross-Sectional Study in a Romanian Cohort
Medical Sciences · 24.07.2026 · 14 (4) · 423
DOI: 10.3390/medsci14040423 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Medical Sciences, online erschienen am 24.07.2026. Verfasst von Ionel-Daniel Nati und 11 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Obstetric and Ginecology, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400610 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms, Uterine Cervical Dysplasia, Human Papillomavirus Viruses. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iuliu Hațieganu University of Medicine and Pharmacy, “Iuliu Hațieganu” University of Medicine and Pharmacy.
Abstract (Originalsprache)
Background
Cervical cancer screening uptake in Romania remains below 20%, with invasive sampling cited as a major participation barrier. Urinary HPV testing is a non-invasive alternative, but data from Eastern European populations are scarce and reporting stratified by histological grade is inconsistent.
Objectives
To evaluate the agreement between paired urinary and clinician-collected cervico-vaginal HPV testing, and to assess the diagnostic performance of urinary HPV testing for biopsy-confirmed cervical intraepithelial neoplasia grade 2 or worse (CIN2+).
Methods
Prospective cross-sectional study in three outpatient obstetrics and gynecology clinics (May 2025–May 2026). A total of 230 women aged 25–70 years provided paired cervico-vaginal (PreservCyt®) and first-void urine (Colli-Pee®) specimens. To capture the full spectrum of disease probability, participants were recruited across three clinical scenarios: primary screening, cytology triage and HPV-positive triage. A multiplex RT-PCR assay targeted a total of 14 high-risk HPV genotypes, providing separate identification for HPV16 and HPV18, alongside a pooled detection for the remaining 12 high-risk strains. Colposcopy-guided cervical biopsy served as the reference standard.
Results
Paired hrHPV testing achieved substantial agreement (κ = 0.696, 95% CI 0.604–0.788), with higher genotype-specific concordance for HPV16 (κ = 0.755) and HPV18 (κ = 0.789). Discordance was directionally asymmetric (30 cervical-positive/urine-negative versus 4 urine-positive/cervical-negative; McNemar p < 0.001). For biopsy-confirmed CIN2+ (59 of 230; 25.7%), urinary hrHPV showed a sensitivity of 86.4% (95% CI 75.5–93.0), specificity 56.7%, positive predictive value 40.8% and negative predictive value 92.4%, compared with 91.5%, 43.3%, 35.8% and 93.7% for cervico-vaginal testing. Urinary HPV positivity increased monotonically with histological severity (25.0% no-lesion, 69.0% CIN1, 86.4% CIN2+; linear-by-linear p < 0.001).
Conclusions
Urinary HPV testing demonstrates substantial agreement with clinician-collected sampling, near-equivalent negative predictive value, and a robust dose–response with histological severity. It is a clinically credible non-invasive entry point for a triage cascade in settings such as Romania, where low participation rather than analytical performance is the principal screening barrier.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 2nd Department of Obstetric and Ginecology, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400610 Cluj-Napoca, Romania.
- Department of Morphofunctional Sciences, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
- HIVE Health Innovation Center, Babeș-Bolyai University, 400094 Cluj-Napoca, Romania.
Förderung
- Iuliu Hațieganu University of Medicine and Pharmacy
- “Iuliu Hațieganu” University of Medicine and Pharmacy
Zitieren
APA
Nati, I. D., Oancea, M., Mihu, C. M., Mihu, D., Ciortea, R., Iuhas, C., Bucuri, C., Roman, M. P., Ormindean, C. M., Suciu, V., Chereches, R., & Malutan, A. M. (2026). Agreement and Diagnostic Performance of Urinary HPV Testing Versus Clinician-Collected Cervico-Vaginal Sampling: A Prospective Cross-Sectional Study in a Romanian Cohort. Medical Sciences, 14(4), 423. https://doi.org/10.3390/medsci14040423
Vancouver
Nati ID, Oancea M, Mihu CM, Mihu D, Ciortea R, Iuhas C, et al. Agreement and Diagnostic Performance of Urinary HPV Testing Versus Clinician-Collected Cervico-Vaginal Sampling: A Prospective Cross-Sectional Study in a Romanian Cohort. Medical Sciences. 2026;14(4):423. doi:10.3390/medsci14040423
BibTeX
@article{Nati2026,
author = {Nati, Ionel-Daniel and Oancea, Mihaela and Mihu, Carmen Mihaela and Mihu, Dan and Ciortea, Razvan and Iuhas, Cristian and Bucuri, Carmen and Roman, Maria Patricia and Ormindean, Cristina Mihaela and Suciu, Viorela and Chereches, Razvan and Malutan, Andrei Mihai},
title = {Agreement and Diagnostic Performance of Urinary HPV Testing Versus Clinician-Collected Cervico-Vaginal Sampling: A Prospective Cross-Sectional Study in a Romanian Cohort},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {4},
pages = {423},
doi = {10.3390/medsci14040423}
}
EUVIMED